Aviva adds neurodiversity pathway support for GIP customers

Signposted support available via Lexxic

Hemma Visavadia
clock • 1 min read

Aviva has added a neurodiversity pathway for group income protection (GIP) customers in a bid to provide support to employees with neurodiverse conditions.

Through access to the pathway, neurodivergent employees can be signposted to Aviva's partner Lexxic which specialises in supporting neurodivergent employees within the workplace. Lexxic also provides coaching and training for employees and colleagues, while its network offers access to chartered and occupational psychologists who can support employees through measures such as screen assessments. Neurodiverse conditions include Dyslexia, DCD (Dyspraxia), Dyscalculia, Autism, Attention Deficit Hyperactivity Disorder (ADHD) and Cognitive Functioning Difficulties. The neurodiversity pa...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Group Protection

Bupa adds benefits to SME health insurance offering

Bupa adds benefits to SME health insurance offering

Includes GP services

Jaskeet Briah
clock 28 May 2026 • 1 min read
Healix Health updates skin cancer screening service

Healix Health updates skin cancer screening service

Partnership with Circle Health Group

Jaskeet Briah
clock 28 May 2026 • 2 min read
Employers concerned about lack of state support for employee health and wellbeing

Employers concerned about lack of state support for employee health and wellbeing

Lack of mental health support felt the most

Jaskeet Briah
clock 22 May 2026 • 2 min read